Search results for "histamine"

showing 10 items of 254 documents

Evaluation of enantioselective binding of antihistamines to human serum albumin by ACE.

2007

The drug binding to plasma and tissue proteins is a fundamental factor in determining the overall pharmacological activity of a drug. HSA, together with alpha(1)-acid glycoprotein, are the most important plasma proteins, which act as drug carriers, with implications on the pharmacokinetic of drugs. Among plasma proteins, HSA possesses the highest enantioselectivity. In this paper, a new methodology for the study of enantiodifferentiation of chiral drugs with HSA is developed and applied to evaluate the possible enantioselective binding of four antihistamines: brompheniramine, chlorpheniramine, hydroxyzine and orphenadrine to HSA. This study includes the determination of affinity constants o…

ChlorpheniramineClinical BiochemistryPlasma protein bindingPharmacologyBiochemistryAnalytical ChemistryPharmacokineticsOrphenadrinemedicineOrphenadrineHumansSerum AlbuminDrug CarriersChromatographyBinding SitesChemistryBiological activityStereoisomerismBrompheniramineHuman serum albuminBrompheniraminebody regionsHydroxyzineembryonic structuresHistamine H1 AntagonistsEnantiomerDrug carriermedicine.drugProtein BindingElectrophoresis
researchProduct

Chromatographic analysis of phenethylamine-antihistamine combinations using C8, C18 or cyano columns and micellar sodium dodecyl sulfate-pentanol mix…

2001

The chromatographic behaviour of binary and ternary mixtures of several phenethylamines (phenylephrine, phenylpropanolamine, ephedrine, pseudoephedrine and methoxyphenamine) and antihistamines (pheniramine, carbinoxamine, doxylamine, chlorpheniramine, dexchlorpheniramine, dexbrompheniramine, diphenhydramine, tripolidine, azatadine and phenyltoloxamine), found in cough-cold pharmaceutical preparations, was studied using C8, C18 and cyano columns, micellar mobile phases of sodium dodecyl sulfate (SDS) and pentanol and UV detection. Using a C8 column and mobile phases of 0.05 mol l-1 SDS-6% v/v pentanol or 0.15 mol l-1 SDS-2% v/v pentanol at pH 7, more than 30 different phenethylamine-antihist…

ChromatographyChromatographyMethoxyphenaminePhenethylaminesPseudoephedrineAscorbic acidBiochemistrySensitivity and SpecificityAnalytical Chemistrychemistry.chemical_compoundNasal DecongestantschemistryPhenyltoloxaminePhenethylaminesElectrochemistrymedicineHistamine H1 AntagonistsEnvironmental ChemistryCarbinoxaminePheniramineSodium dodecyl sulfateSpectroscopymedicine.drugThe Analyst
researchProduct

Characterization of antihistamine–human serum protein interactions by capillary electrophoresis

2007

An important topic in the drug discovery and development process is the role of drug binding to plasma proteins. In this paper the characterization of the interaction between antihistamines (cationic drugs) towards human serum albumin (HSA) and alpha(1)-acid glycoprotein (AGP) under physiological conditions by capillary electrophoresis-frontal analysis is presented. Furthermore, the binding of these drugs to all plasma proteins is evaluated by using ultrafiltration and capillary electrophoresis. Antihistamines present a wide-ranging behaviour with respect to their affinities towards plasma proteins. Orphenadrine, phenindamine, tripelenamine and tripolidine principally bind to HSA; carbinoxa…

ChromatographyPhenindamineChemistryOrganic ChemistryElectrophoresis CapillaryBlood ProteinsGeneral MedicinePlasma protein bindingBrompheniramineHuman serum albuminBiochemistryBlood proteinsAnalytical Chemistrychemistry.chemical_compoundChlorcyclizineBiochemistryDimetindeneHistamine H1 AntagonistsmedicineHumansCarbinoxamineProtein Bindingmedicine.drugJournal of Chromatography A
researchProduct

Study on the histamine-like activity of guanfacine

1990

Abstract The effects of guanfacine have been studied on guinea-pig isolated atria and diethylstilboestrol-treated rat isolated uterus to determine whether it possesses histamine-like activity. Guanfacine produced a concentration-dependent negative chronotropic effect which was not modified by ranitidine (0.1 μM). In rat isolated uterus contracted by KCl, clonidine (5–5000 μM) produced concentration-dependent relaxation which was blocked by ranitidine (0.1 μM), but guanfacine only produced relaxation at high concentrations (100–1000 μM), and this was not affected by ranitidine (0.1 μM). It is concluded that guanfacine, unlike clonidine, does not produce effects due to activation of H2-recept…

Chronotropicmedicine.medical_specialtyGuinea PigsUterusPharmaceutical SciencePharmacologyClonidinePotassium ChlorideGuinea pigRanitidineUterine Contractionchemistry.chemical_compoundInternal medicinemedicineAnimalsHeart AtriaDiethylstilbestrolPharmacologyDose-Response Relationship Drugbusiness.industryRats Inbred StrainsMyocardial ContractionGuanfacineRatsGuanfacineClonidineEndocrinologymedicine.anatomical_structureMechanism of actionchemistryFemalemedicine.symptombusinessAdrenergic alpha-AgonistsHistaminemedicine.drugJournal of Pharmacy and Pharmacology
researchProduct

Exposure to Gastric Acid Inhibitors Increases the Risk of Infection in Preterm Very Low Birth Weight Infants but Concomitant Administration of Lactof…

2018

Objective: To investigate whether exposure to inhibitors of gastric acidity, such as H2 blockers or proton pump inhibitors, can independently increase the risk of infections in very low birth weight (VLBW) preterm infants in the neonatal intensive care unit. Study design: This is a secondary analysis of prospectively collected data from a multicenter, randomized controlled trial of bovine lactoferrin (BLF) supplementation (with or without the probiotic Lactobacillus rhamnosus GG) vs placebo in prevention of late-onset sepsis (LOS) and necrotizing enterocolitis (NEC) in preterm infants. Inhibitors of gastric acidity were used at the recommended dosages/schedules based on the clinical judgmen…

ColonizationProton Pump InhibitorNeonatal intensive care unitAdministration OralHistamine H2 AntagonistProbioticGastroenterologyPediatricsH2 blocker0302 clinical medicineRisk FactorsInfant Very Low Birth Weight030212 general & internal medicineCandidaVLBW neonateLacticaseibacillus rhamnosusGestational agePerinatology and Child HealthHistamine H2 AntagonistsItalyNecrotizing enterocolitismedicine.symptomInfectionInfant PrematureHumanmedicine.medical_specialtyBirth weightGastric AcidSepsis03 medical and health sciencesEnterocolitis NecrotizingIntensive Care Units NeonatalSepsis030225 pediatricsInternal medicinemedicineH2 blockersHumansDietary Supplementbusiness.industryRisk FactorProbioticsInfant NewbornProton Pump Inhibitorsmedicine.diseaseLow birth weightLactoferrinConcomitantDietary SupplementsPediatrics Perinatology and Child HealthVLBW neonatesCandida; Colonization; H2 blockers; Infection; Lactoferrin; VLBW neonates; Pediatrics Perinatology and Child HealthGastric acidLactobacillus rhamnosubusinessNew Zealand
researchProduct

The relaxant effects of cromakalim (BRL 34915) on human isolated airway smooth muscle

1992

Cromakalim (BRL 34915) is a potassium channel opener with therapeutic potential as a bronchodilator in asthma. Cromakalim (0.1–30 μmol/l) inhibited the spontaneous tone of human isolated bronchi n a concentration-related manner being nearly as effective as isoprenaline or theophylline. The order of relaxant potencies (expressed as -log10 IC50 mol/l; mean ±SEM) was isoprenaline (7.29 ± 0.27; n = 8) > cromakalim (5.89 ± 0.12; n = 7) > theophylline (4.07 ±0.13; n = 10). In human bronchi where tone had been raised by addition of histamine (0.1 mmol/l), acetylcholine (0.1 mmol/l) or leukotriene D4 (LTD4, 0.1 μmol/l), the relaxant effect of cromakalim was substantially reduced. Cromakalim suppres…

CromakalimMuscle RelaxationBronchiPharmacologyGlibenclamidechemistry.chemical_compoundTheophyllineIsoprenalinemedicineHumansBenzopyransDrug InteractionsPyrrolesPharmacologyTetraethylammoniumIsoproterenolMuscle SmoothGeneral MedicineAcetylcholineBronchodilator AgentschemistryAnesthesiaSRS-APotassium channel openermedicine.symptomCromakalimHistamineAcetylcholineHistamineMuscle contractionmedicine.drugNaunyn-Schmiedeberg's Archives of Pharmacology
researchProduct

Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus monteluk…

2004

BACKGROUND: Corticosteroids are considered to be particularly effective in reducing nasal congestion and are therefore recommended as first-line treatment in allergic rhinitis patients with moderate to severe and/or persistent symptoms. OBJECTIVE: We compared the clinical efficacy of fluticasone propionate aqueous nasal spray (FPANS) 200 microg given once daily, administered in mono-therapy or combined therapy with a H1 receptor antagonist (cetirizine, CTZ) or with a leukotriene antagonist (montelukast, MSK), and the combined therapy of CTZ plus MSK in the treatment of patients affected by allergic rhinitis to Parietaria during natural pollen exposure. In addition, we examined the effect of…

CyclopropanesMaleAllergySettore MED/09 - Medicina Internamedicine.medical_treatmentseasonal allergic rhinitisAcetatesGastroenterologyImmunology and AllergyMedicineChildFluticasonepollen seasonRandomized placebo-controlled trialBlood Proteinsrespiratory systemEosinophil Granule ProteinsMiddle AgedCetirizineAnesthesiamontelukastHistamine H1 AntagonistsQuinolineseosinophil cationic proteinDrug Therapy CombinationFemaleeosinophilsmedicine.symptommedicine.drugAdultmedicine.medical_specialtyAdolescentImmunologyNasal congestionSulfidesPlaceboFluticasone propionateDrug Administration ScheduleRibonucleasesDouble-Blind MethodInternal medicineHumansRandomized placebo-controlled trial; fluticasone; cetirizine; montelukast; seasonal allergic rhinitisGlucocorticoidsMontelukastAdministration IntranasalAnalysis of Variancerhinorrheafluticasone propionatebusiness.industrynasal lavageRhinitis Allergic Seasonalmedicine.diseaseCetirizineAndrostadienesParietariaNasal sprayFluticasoneLeukotriene AntagonistsNasal administrationbusinessClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
researchProduct

Which lactic acid bacteria are responsible for histamine production in wine?

2005

Aims: To quantify the ability of 136 lactic acid bacteria (LAB), isolated from wine, to produce histamine and to identify the bacteria responsible for histamine production in wine. Methods and Results: A qualitative method based on pH changes in a plate assay was used to detect wine strains capable of producing high levels of histamine. Two quantitative, highly sensitive methods were used, an enzymatic method and HPLC, to quantify the histamine produced by LAB. Finally, an improved PCR test was carried out to detect the presence of histidine decarboxylase gene in these bacteria. The species exhibiting the highest frequency of histamine production is Oenococcus oeni. However, the concentrati…

DNA Bacterialved/biology.organism_classification_rank.speciesWineLactobacillus hilgardiiHistidine DecarboxylaseGram-Positive BacteriaApplied Microbiology and BiotechnologyPolymerase Chain Reactionchemistry.chemical_compoundLactobacillusPediococcusHistamine ProductionChromatography High Pressure LiquidWinemakingOenococcus oenibiologyved/biologyfood and beveragesGeneral Medicinebiology.organism_classificationLactobacilluschemistryBiochemistryGenes BacterialFood MicrobiologyPediococcusHistamineOenococcusLeuconostocBiotechnologyHistamineJournal of applied microbiology
researchProduct

The effects of short-term immunotherapy using molecular standardized grass and rye allergens compared with symptomatic drug treatment on rhinoconjunc…

2005

The efficacy and safety of short-term immunotherapy with molecular standardized allergens (STI) has been demonstrated by double-blind placebo-controlled clinical trials. The aim of this study was to compare STI with symptomatic drug treatment.Forty-eight patients with rhinoconjunctivitis to grass and/or rye pollen were treated either with STI (ALK(7), n = 24) plus anti-allergic drugs or anti-allergic drugs, alone (n = 24) in a prospective, randomized study. Symptoms and use of drugs were reported in patient diaries and titrated nasal provocation and skin prick tests were performed at baseline, before, and after season.Median overall symptom (P = 0.022, U test) and medication scores (P = 0.0…

DrugAdultMalemedicine.medical_specialtyNasal Provocation TestsAdolescentmedia_common.quotation_subjectmedicine.medical_treatmentProvocation testRespiratory System AgentsPoaceaeNasal provocation testlaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicineotorhinolaryngologic diseasesMedicineHumansProspective Studies030223 otorhinolaryngologyProspective cohort studymedia_commonDesensitization (medicine)Conjunctivitis AllergicSkin Testsbusiness.industryRhinitis Allergic SeasonalImmunotherapyAntigens PlantMiddle AgedClinical trialTreatment OutcomeOtorhinolaryngologyDesensitization Immunologic030220 oncology & carcinogenesisImmunologyHistamine H1 AntagonistsSurgeryFemalebusinessFollow-Up StudiesOtolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
researchProduct

The role of histamine in doxorubicin and teniposide-induced cardiotoxicity in dog and mouse.

1987

In previous studies we reported that teniposide (VM26) induced acute cardiac effects in dogs seem to be related to a release of histamine and that a prior treatment with chlorpheniramine, an H, histamine blocker, prevents the onset of this phenomenon. Since histamine and other vasoactive substances also seem to be involved in doxorubicin (DXR)-induced acute cardiac effects, experiments were undertaken in the aim to prevent, as in the case of VM26, the onset of this phenomenon by administering chlorpheniramine. Since DXR-induced chronic cardiomyopathy also seems to be related to the same mechanisms involved in the onset of acute cardiac effects induced by this drug, additional studies were …

DrugMaleCancer ResearchChlorpheniraminedoxorubicincardiotoxicity.media_common.quotation_subjectCardiomyopathyPharmacology030218 nuclear medicine & medical imaging03 medical and health scienceschemistry.chemical_compoundMice0302 clinical medicineDogsVasoactiveMedicineAnimalsDoxorubicinmedia_commonPodophyllotoxinTeniposideCardiotoxicitybusiness.industryMyocardiumHeartGeneral Medicinemedicine.diseaseOncologychemistryDoxorubicin030220 oncology & carcinogenesisInotropismFemalebusinessHistamineTeniposidemedicine.drugHistamineTumori
researchProduct